-
STRATA Skin Sciences receives CMS approval for expanded excimer laser codes
-
STRATA wins court ruling against LaserOptek in false advertising case
-
STRATA Skin Sciences reports excimer laser study results for rare lymphoma
-
STRATA highlights clinical evidence for XTRAC laser in eczema treatment
-
STRATA Skin Sciences study shows laser-drug combo improves psoriasis
-
STRATA study shows excimer laser plus JAK inhibitor treats vitiligo
-
STRATA Skin Sciences reports clinic partner revenue growth from consulting program
-
STRATA Skin Sciences patents cover excimer laser combination therapies
-
Strata Skin Sciences (SSKN) PT Lowered to $4 at Maxim Group
-
STRATA Skin Sciences (SSKN) Misses Q2 EPS by 60c
-
STRATA seeks early Medicare coverage for expanded laser treatments
-
STRATA Skin Sciences (SSKN) Misses Q4 EPS by 58c
-
STRATA Skin Sciences (SSKN) Highlights New Clinical Study from Japan Demonstrating Superiority of Narrow Band Excimer Laser Over Non Narrow Band UVB-Source Like Excimer Light
-
STRATA Skin Sciences (SSKN) Files $25M Mixed Shelf
-
STRATA Skin Sciences (SSKN) Misses Q3 EPS by 53c
-
STRATA Skin Sciences (SSKN) Announces Favorable Court Order in Complaint Against LaserOptek, Monarch Laser Services, and The Pinnacle Health Group
-
STRATA Skin Sciences, Inc. (SSKN) Tops Q2 EPS by 3c
-
STRATA Skin Sciences (SSKN) Announces Approval of XTRAC Momentum 1.0 Device in Japan

